- Appendiceal cancer treatment involves a multidisciplinary approach including surgery, chemotherapy, and targeted therapies, and is becoming increasingly significant due to rising awareness and diagnostic capabilities that enable earlier detection of this rare malignancy in both primary and metastatic stages
- The growing demand for effective appendiceal cancer treatments is primarily fueled by improved imaging technologies, increased healthcare access, and advancements in personalized oncology that enable more tailored and effective therapeutic strategies
- North America dominated the appendiceal cancer treatment market with the largest revenue share of 39% in 2024, characterized by advanced healthcare infrastructure, strong research funding, and a concentration of clinical trials and leading cancer centers in the U.S., which continues to see increasing incidence reporting and innovation in treatment protocols
- Asia-Pacific is expected to be the fastest growing region in the appendiceal cancer treatment market during the forecast period due to improved cancer awareness, expanding healthcare coverage, and investments in oncology research
- Surgery segment dominated the appendiceal cancer treatment market with a market share of 47% in 2024, driven by its role as the primary and often curative treatment option, especially when combined with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC)
